SFTPC and lung disorder: The role of NKX2.1 in lung diseases may be because of its potential to modulate SP-A, SP-B, and SP-C expressions (Yang et al., 2006; Islam and Mendelson, 2008; Zhou et al., 2008; Knabe et al., 2016).